ACADIA Pharmaceuticals In... (ACAD)
NASDAQ: ACAD
· Real-Time Price · USD
21.10
-0.24 (-1.12%)
At close: Oct 01, 2025, 1:51 PM
-1.12% (1D)
| Bid | 18.17 |
| Market Cap | 3.56B |
| Revenue (ttm) | 1.02B |
| Net Income (ttm) | 222.16M |
| EPS (ttm) | 1.35 |
| PE Ratio (ttm) | 15.63 |
| Forward PE | 25.69 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 24.22 |
| Volume | 989,710 |
| Avg. Volume (20D) | 2,017,309 |
| Open | 21.33 |
| Previous Close | 21.34 |
| Day's Range | 21.05 - 21.54 |
| 52-Week Range | 13.40 - 26.65 |
| Beta | 0.75 |
| Ex-Dividend Date | n/a |
About ACAD
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol ACAD
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for ACAD stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsACADIA Pharmaceuticals Inc. is scheduled to release its earnings on
Nov 5, 2025,
after market closes.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
1 week ago
-9.92%
Acadia Pharmaceuticals shares are trading lower af...
Unlock content with
Pro Subscription
4 months ago
+26.48%
ACADIA Pharmaceuticals shares are trading higher after a court decision ruled in favor of the company regarding patent infringement claims over Nuplazid.
